Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|January 2, 2024
Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantationMuhammad Umair Mushtaq, Moazzam Shahzad, Muhammad K Amin, et al.
Frontiers in Immunology|May 11, 2023
Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysisMoazzam Shahzad, Andrea Nguyen, Ali Hussain, et al.
Cancers|November 13, 2025
Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed IntervalsJordan Snyder, Shebli Atrash, Barry Paul, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible PatientsRaeef Rahman, Anas Zayad, Carmel Awadallah, et al.
Critical Reviews in Oncology/Hematology|February 29, 2024
Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysisMoazzam Shahzad, Qamar Iqbal, Ezza Tariq, et al.
Hematology/Oncology and Stem Cell Therapy|April 1, 2024
Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic ReviewMoazzam Shahzad, Muhammad Fareed Khalid, Muhammad Kashif Amin, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 22, 2023
Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-AnalysisMoazzam Shahzad, Ali Hussain, Ezza Tariq, et al.
European Journal of Haematology|May 12, 2026
Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T RecipientsChiranjeevi Sainatham, Olga Goloubeva, Philip Margiotta, et al.
Frontiers in Immunology|October 20, 2022
Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysisMuhammad Umair Mushtaq, Moazzam Shahzad, Amna Y Shah, et al.
Leukemia & Lymphoma|June 10, 2022
Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysisRazwana Khanam, Moazzam Shahzad, Sibgha Gull Chaudhary, et al.
Pageof 8